Terns Pharmaceuticals (TERN)

• Market cap: $714M
• 1 day: 1.75%
• 5 days: 10.12%
• 1 month: 8.66%
• 3 months: 38.07%
• 6 months: 147.27%
• Year to date: 43.92%
• 1 year: 18.43%
• 5 years: -55.63%
• 10 years: -55.63%
• Sector: Healthcare
• Industry: Biotechnology

About: Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Employees: 59